Ares Management Corp. (ARES) Social Stream

Featured Post From StockTwits About ARES

$OPGN A FUND, $SPY $QQQ, WILL DO VERY WELL IN THE 2'S: Risk/Reward the best I've ever seen: Company needs to issue guide, because the market doesn't understand the value here. Below is my summation; massively undervalued. Science is unsurpassed. Unyvero can identify and stop the next deadly pathogen. I believe, and please correct me if I'm wrong, that the CEO said that this is the most comprehensive test with 8000 markers? FDA PENDING/DUE IN THE NEXT 8 TRADING DAYS.
Math is as follows: OPGN ACQUIRES $ARES GENETICS & $CURETIS
$8 - $10 PER SHARE,
$OPGN secures deal with CDC/State of New York/35 Hospitals
$15 per share,
$OPGN inks a 8 year 181M deal with
$CHINA BIO $25 per share,
$OPGN signs deal with Columbia, and secures Menari Partnership $28, $OPGN achieves the equivalent of FDA in China, (GDP significant),
$OPGN Receives note from US FDA l is due now; August. $40-$50 per share. AT $2 TRADE IS ARTIFICALLY DEPRESSED AND MASSIVELY UNDERVALUED. BACK UP THE TRUCK

What Else are ARES Traders Talking About?

Other tickers frequently mentioned alongside ARES are OPGN, SPY and QQQ.